Boston Therapeutics, Inc. Share Price Other OTC
Equities
BTHE
US1011501004
Advanced Medical Equipment & Technology
Sales 2021 | 142K 11.17M | Sales 2022 | 15.45K 1.22M | Capitalization | 9.32M 734M |
---|---|---|---|---|---|
Net income 2021 | -9M -709M | Net income 2022 | -12M -946M | EV / Sales 2021 | 149 x |
Net Debt 2021 | 4.52M 356M | Net Debt 2022 | 11.39M 898M | EV / Sales 2022 | 1,340 x |
P/E ratio 2021 |
-1.75
x | P/E ratio 2022 |
-0.62
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 42.05% |
Managers | Title | Age | Since |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 18/01/23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
1st Jan change | Capi. | |
---|---|---|
+9.80% | 34.16B | |
+24.92% | 8.13B | |
+36.69% | 4.44B | |
-28.70% | 2.7B | |
-20.62% | 1.37B | |
-28.50% | 1.27B | |
-32.48% | 1.18B | |
+12.29% | 1B | |
-37.86% | 870M |